Home · Open Lab · Lot RGX-26-RGX-1002
RGX-26-RGX-1002Current
GLP-3-RT · 20 MG · Metabolic Research · COA NS-2026-05003

Release test results

99.587%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 20.14 mg
Related impurities (total)0.413%
Endotoxin<1.0 EU/mg
HPLC retention time9.5 min
MethodHPLC + LC-MS
ResultPass · meets spec

Lot record

CompoundGLP-3-RT
Presentation20 MG
Lot numberRGX-26-RGX-1002
COA numberNS-2026-05003
Test date03 Sep 2026
Release date06 Sep 2026
Independent labNordicstar Labs
StatusCurrent

GLP-3-RT — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-RGX-100115 MGSep 8, 202699.770%Current
RGX-26-RGX-100440 MGSep 8, 202699.594%Current
RGX-26-RGX-69640 MGSep 8, 202699.728%Superseded
RGX-26-RGX-100010 MGSep 7, 202699.663%Current
RGX-26-RGX-69915 MGSep 7, 202699.714%Superseded
RGX-26-RGX-69820 MGSep 7, 202699.576%Superseded
RGX-26-RGX-100330 MGSep 6, 202699.556%Current
RGX-26-RGX-80010 MGSep 6, 202699.607%Superseded
RGX-26-RGX-79460 MGSep 6, 202699.690%Superseded
RGX-26-RGX-79820 MGSep 5, 202699.676%Superseded
RGX-26-RGX-79640 MGSep 5, 202699.759%Superseded
RGX-26-RGX-100660 MGSep 4, 202699.739%Current
RGX-26-RGX-70010 MGSep 4, 202699.569%Superseded
RGX-26-RGX-69550 MGSep 4, 202699.652%Superseded
RGX-26-RGX-1002 this lot20 MGSep 3, 202699.587%Current
RGX-26-RGX-69730 MGSep 3, 202699.721%Superseded
RGX-26-RGX-79550 MGSep 3, 202699.766%Superseded
RGX-26-RGX-100550 MGSep 2, 202699.701%Current
RGX-26-RGX-79915 MGSep 2, 202699.752%Superseded
RGX-26-RGX-79730 MGSep 2, 202699.614%Superseded
RGX-26-RGX-69460 MGSep 2, 202699.659%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →